Transparency Market Research Report Added "Small Molecule Targeted Cancer Therapy Market" to its database.

Albany, NY -- (SBWire) -- 02/16/2016 --A new market research report by Transparency Market Research, titled "Small Molecule Targeted Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," helps in the evaluation of the trends in the market for small molecule targeted cancer therapy. The report also includes a review of the prime factors that are inhibiting and enhancing the growth of the market and this helps the stakeholders gain a detailed understanding of the market. In addition, the report also comprises analysis using the Porter's five forces model and this helps in understanding the threats posed by new entrants and the bargaining powers of both suppliers and buyers. Moving further, the report also lists the prime strategies adopted by top-notch companies operating in the market, coupled with the mergers and acquisitions, collaborations and agreements, and product launches done by these companies. Furthermore, the report also comprises distinctive graphics as well as SWOT analysis of the prime market segments.

Request for Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2107

As stated in the report, the rising occurrence of cancer and the minimal side effects related to small molecule targeted therapy are amongst the major factors driving the market for small molecule targeted cancer therapy. In addition, the increasing rate of adoption of this therapy and the patent loss of various blockbuster drugs such as Novartis's Glivec have also raised a lot of substantial opportunities for the targeted cancer drugs manufacturers, thus boosting the market. On the other hand, factors such as strict regulatory policies, relatively low awareness amongst people, and the soaring costs of development may impede the growth of the market in forthcoming years.

The report segments targeted cancer drugs into monoclonal antibodies, small drug conjugates, and small molecules. Amongst these, small molecules are further segmented into small molecule cyclin-dependent kinase inhibitors, small molecule proteasome inhibitors, and small molecule tyrosine kinase inhibitors.

In terms of geography, the report segments the small molecule targeted cancer therapy market into Asia Pacific, North America, Europe, and Rest of the World (RoW). Amongst these, North America held the largest share in the market owing to the increasing number of cases of cancer in this region. As per the World Cancer Report, the occurrence of cancer will further increase by 50% by 2020. On the other hand, the regions of Asia Pacific and Europe are also anticipated to experience growth in the market for small molecule targeted cancer therapy owing to the commercialization of target-oriented economic drugs within this region.

As per this report, the prominent players in the market are Bayer HealthCare AG, Abbott Laboratories, Boehringer Ingelheim GmbH, OncoGenex Pharmaceuticals Inc., and GlaxoSmithKline plc., CytokineticsInc., and Hospira Inc., among others.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/